 to pain, mobility, varicose vein recurrence,
and QOL scores during the 1-year follow-up. A significantly
higher proportion of patients in the no-SEPS group had
incompetent perforating veins on duplex imaging at 1 year
(25 of 32 vs 12 of 38; P ‚¨ç .001). This RCT concluded that at
1 year in class C2 patients, no additional clinical benefit could
be